L'oreal

Nestec S.a.

Societe Des Produits Nestle S.a.

Societe L'oreal Sa

Nutricos Technologies

Xl'oreal

Isabelle Castiel

Audrey Gueniche

Dominique Bernard

Lionel Breton

Rachid Bel-Rhlid

Lucie Simonetti

Jean-Thierry Simonnet

Yann Mahe

Nicolas Page

Thomas Raab

Corinne Ferraris

Vanessa Crespy

Bruno Bernard

Quintino Gaetani

Cristina Cruz-Hernandez

Mark Donovan

Carole Bru

Caroline Delattre

David Amar

Marjorie Marie-Carmen Guitard

Frédéric Destaillats

Veronique Chaussade

Mélanie Chopart

Christele Guey

Eric Arbey

Armelle Lavalle-Bouchard

Armelle LaValle-Bouchard

Arnelle Bouchard

Véronique Chaussade

Cosmetic use of an effective amount of a lysate of at least one microorganism of the genusspecies and/or one of its fractions in treating and/or preventing dryness and/or associated disorders of a keratinous substance.

Cosmetic use ofspecies lysate for the treatment of dryness

The invention relates to the cosmetic use of an effective amount of at least one monounsaturated fatty acid, of a salt thereof and/or of an ester thereof, as a nailcare active agent.

Monounsaturated fatty acid for nailcare

Cosmetic use of an effective amount of at least one lysate of at least one microorganism of the genusspecies and/or a fraction thereof, for preventing and/or treating a skin disorder in the case of sensitive skin.

Use of a lysate of bifidobacterium species for treating sensitive skin

The present invention relates to the cosmetic treatment of greasy skin and/or skin that tends to be greasy with a lysate of at least one microorganism of the genusspecies and/or a fraction thereof, as an active.

Treatment of greasy skin with a bacterial lystate

The invention relates to the oral or nutraceutical cosmetic use of an effective amount of at least one monounsaturated fatty acid, a salt thereof and/or an ester thereof, as an active agent for treating and/or preventing skin complexion imperfections.

Monounsaturated fatty acid for preventing and/or treating skin complexion imperfections

The present invention relates to compositions of rosmarinic acid or its derivatives and to the use of a hydrolytic enzyme or of microorganism containing or producing hydrolytic enzymes in these compositions. The invention also pertains to methods for improving the biological effects of the rosemary extracts and for administering such compositions to a human or animal subject for improving the skin, coat, hair or health of the subject.

Biological effects of compositions of rosmarinic acid

The present invention relates to the use, especially the cosmetic and/or therapeutic use, of the protein DJ-1, of polypeptides derived from this protein or of analogs thereof, of a nucleic acid sequence coding for such a polypeptide or of a modulator of the activity, stability or expression of such a polypeptide, especially for preventing and/or treating the signs of skin dryness. The invention also relates to the use of the protein DJ-1, of polypeptides derived from this protein or of analogs thereof or of a nucleic acid sequence coding for such a polypeptide, as a marker for evaluating the state of dryness of an epithelium.

Cosmetic and therapeutic use of proteins of DJ-1 type for treating skin dryness

The present invention relates to a use of an effective amount of at least one probiotic microorganism and/or a fraction thereof and/or a metabolite thereof for preventing and/or treating dandruff disorders of the scalp, as well as a cosmetic process for preventing and/or treating a dandruff condition including the administration a first cosmetic active agent and of at least a second cosmetic active agent, topically, the said first and second cosmetic active agents being formulated in separate compositions, the first cosmetic active agent being chosen from probiotic microorganisms, and mixtures thereof, and the second cosmetic active agent being chosen from antidandruff active agents.

Cosmetic use of microorganism(s) for the treatment of scalp disorders

The present invention relates to the use, in cosmetics and in therapeutics, of at least one antimicrobial protein belonging to the ribonuclease family, ribonuclease 7, or of polypeptides derived from said protein, notably as a marker for evaluating the condition of the epidermis. It further relates to the use of at least one polypeptide according to the invention, of at least one nucleic acid sequence coding for a polypeptide according to the invention, or of at least one agent that modulates the expression or the activity, notably biological, of said polypeptide or of its interaction with an element of the extracellular matrix, for the preparation of compositions intended for the prevention and/or treatment of skin disorders.

Cosmetic use of a protein belonging to the ribonuclease family

The present invention relates to the cosmetic use of an effective amount of at least one probiotic microorganism and/or a fraction thereof and/or a metabolite thereof, as an agent for treating and/or preventing oily skin or skin with an oily tendency and the associated skin disorders.

Cosmetic use of microorganisms for the treatment of oily skin

Biological effects of compositions comprising rosmarinic acid

The subject of the present invention is the use, in particular the cosmetic and/or therapeutic use, of the apolipoprotein D, of polypeptides derived from this protein or of analogues thereof, of a nucleic sequence encoding such a polypeptide or of an agent modulating the activity or of the expression of such a polypeptide, in particular for stimulating terminal epithelial differentiation. The invention also relates to the use of the protein apolipoprotein D, of polypeptides derived from this protein or of analogues thereof, or of a nucleic sequence encoding such a polypeptide as a marker for evaluating the state of the epidermis.

Cosmetic use of apolipoprotein D type proteins

At least one phytosphingosine salicylate derivative and at least one lysate of at least one microorganism of the genus. Composition, combination. Use, including cosmetic use for reinforcing the repair and regeneration capacity of an epithelium, especially an epidermis, in particular an aged epidermis.

Combination of a microorganism and a phytosphingosine derivative, composition, methods of use

A reconstructed epidermis/skin equivalent supplemented with at least one ceramide 7 and/or 5.5 compound, suited for reinforcing the barrier function of normal human epidermis and for improving the barrier function of dry skin and of reconstructed skin or skin equivalents, is prepared by introducing the at least one ceramide 7 and/or 5.5 compound into the culture medium of such reconstructed epidermis/skin equivalent and/or topically applying onto the face surface of such reconstructed epidermis/skin equivalent a composition which comprises lipid lamellar vesicles incorporating at least one ceramide 7 and/or 5.5 compound.

Reconstructed epidermis/skin equivalent comprising a ceramide 7 and /or 5.5 and lipid lamellar vesicular compositions comprising ceramide 7 and/or 5.5 compounds

Novel ceramide compounds, compositions containing them and the use of these compounds, in particular for strengthening the lipid barrier of the epidermis.

Growing community of inventors

Nice, France

Isabelle Castiel